Suppr超能文献

透壁愈合是炎症性肠病可实现的目标吗?

Is Transmural Healing an Achievable Goal in Inflammatory Bowel Disease?

作者信息

Faggiani Ilaria, Solitano Virginia, D'Amico Ferdinando, Parigi Tommaso Lorenzo, Zilli Alessandra, Furfaro Federica, Peyrin-Biroulet Laurent, Danese Silvio, Allocca Mariangela

机构信息

Department of Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, 20132 Milan, Italy.

Department of Epidemiology and Biostatistics, Western University, London, ON N6A 3K7, Canada.

出版信息

Pharmaceuticals (Basel). 2025 Jul 27;18(8):1126. doi: 10.3390/ph18081126.

Abstract

: In the era of treat-to-target strategies in inflammatory bowel disease (IBD), transmural healing (TH) is gaining recognition as a promising therapeutic goal. TH has been associated with significantly better long-term outcomes, including reduced rates of hospitalization, surgery, and the need for therapy escalation. Cross-sectional imaging techniques, such as intestinal ultrasound (IUS), magnetic resonance imaging (MRI), and computed tomography enterography (CTE), offer a comprehensive, non-invasive means to assess this deeper level of healing. This review explores how TH is currently defined across various imaging modalities and evaluates the feasibility and cost-effectiveness of achieving TH with available therapies. : A literature search was conducted across PubMed, Scopus, and Embase using keywords, including "transmural healing", "intestinal ultrasonography", "magnetic resonance imaging", "computed tomography enterography", "Crohn's disease", "ulcerative colitis", and "inflammatory bowel disease". Only English-language studies were considered. : Despite growing interest, there is no standardized definition of TH across imaging platforms. Among the modalities, IUS emerges as the most feasible and cost-effective tool, owing to its accessibility, accuracy (sensitivity 62-95.2%, specificity 61.5-100%), and real-time capabilities, though it does have limitations. Current advanced therapies induce TH in roughly 20-40% of patients, with no consistent differences observed between biologics and small molecules. However, TH has only been evaluated as a formal endpoint in a single randomized controlled trial to date. A unified and validated definition of transmural healing is critically needed to harmonize research and guide clinical decision-making. While TH holds promise as a meaningful treatment target linked to improved outcomes, existing therapies often fall short of achieving complete transmural resolution. Further studies are essential to clarify its role and optimize strategies for deep healing in IBD.

摘要

在炎症性肠病(IBD)的达标治疗策略时代,透壁愈合(TH)正逐渐被视为一个有前景的治疗目标。TH与显著更好的长期预后相关,包括住院率、手术率降低以及治疗升级需求减少。横断面成像技术,如肠道超声(IUS)、磁共振成像(MRI)和计算机断层扫描小肠造影(CTE),提供了一种全面、非侵入性的方法来评估这种更深层次的愈合情况。本综述探讨了目前在各种成像方式中TH是如何定义的,并评估了现有疗法实现TH的可行性和成本效益。:使用关键词在PubMed、Scopus和Embase上进行了文献检索,关键词包括“透壁愈合”、“肠道超声检查”、“磁共振成像”、“计算机断层扫描小肠造影”、“克罗恩病”、“溃疡性结肠炎”和“炎症性肠病”。仅纳入英文研究。:尽管关注度不断提高,但跨成像平台对TH尚无标准化定义。在这些成像方式中,IUS因其可及性、准确性(敏感性62 - 95.2%,特异性61.5 - 100%)和实时能力而成为最可行和最具成本效益的工具,不过它确实存在局限性。目前的先进疗法在大约20% - 40%的患者中诱导出TH,生物制剂和小分子药物之间未观察到一致差异。然而,迄今为止,TH仅在一项随机对照试验中作为正式终点进行了评估。迫切需要一个统一且经过验证的透壁愈合定义,以协调研究并指导临床决策。虽然TH有望成为一个与改善预后相关的有意义的治疗靶点,但现有疗法往往难以实现完全的透壁病变消退。进一步的研究对于阐明其在IBD中的作用并优化深度愈合策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c56c/12389124/d63c0b5b0cdc/pharmaceuticals-18-01126-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验